Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

The US Patent and Trademark Office (USPTO) has granted a patent to Vistagen’s non-opioid oral product candidate, AV-101 for ...

Predicting who will transition from acute to chronic pain is the “holy grail” of pain neuroscience. A novel biomarker ...

A novel biomarker signature combining PAF and CME predicts chronic pain risk, linking brain activity to individual pain ...

"The combination of biomarker accuracy, reproducibility, reliability, and pain model validity suggests high potential for clinical translation, particularly in predicting the transition from acute ...

Chicago, IL, USA), Tony discusses how they used opti-ox to generate nociceptor sensory neurons that respond efficiently to stimuli, providing a potential pain model that could help develop more ...

No matter the culprit, be it tendonitis, carpal tunnel or arthritis, hand and wrist pain can majorly impede your daily life.

A novel biomarker signature that assessed cortical activity predicted individual pain sensitivity, the PREDICT validation ...

Irritable bowel syndrome (IBS) is a common digestive disorder with unclear causes, affecting about 10% of the global population. Researchers have now discovered that opioid delta-receptor agonists may ...

It’s been six months since the state resumed control of the Lawrenceville Correctional Center. It was the only privately ...

Scientists at Google DeepMind and the London School of Economics and Political Science (LSE) are trying to figure out how to determine if artificial ...

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new ...